Harnessing the FGFR2/NF2/YAP signaling-dependent necroptosis to develop an FGFR2/IL-8 dual blockade therapeutic strategy

Journal:

Nature Communications

Published:

2025-05-03

DOI:

10.1038/s41467-025-59318-9

Affiliations:

7

Authors:

16

Go to article

Institutions	Authors	Share
State Key Laboratory of Molecular Oncology, China	13.033333 13.033333	0.81
State Key Laboratory of Oncology in South China, SYSUCC, China	1.500000	0.09
Institute of Cancer Research, Shenzhen Bay Laboratory, China	0.533333	0.03
Peking University Shenzhen Hospital, China	0.533333	0.03
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	0.200000	0.01
Soochow University, China	0.200000	0.01

Interested in Oncology and Carcinogenesis?